Optimizing Parameters of Transcranial Temporal Interference Stimulation for Spinocerebellar Ataxia Type 3
Key facts
- Who runs it
- First Affiliated Hospital of Fujian Medical University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 24 people, planned
- Started
- 7 Aug 2026
- Expected to end
- 28 Feb 2027
- Type of study
- Interventional, 3 groups
- Treatments tested
- Transcranial Temporal Interference Stimulation (tTIS)
- Record updated
- 1 September 2026
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (14)Hide the full registry criteria
Who can take part
- A physician-diagnosed SCA3 according to diagnostic criteria, with definite clinical symptoms and confirmed genetic testing
- Age 18-75 years
- Baseline total score of SARA: 8-30 points (inclusive); SARA gait function subscore: 2-6 points (inclusive)
- Willing to participate and provide informed consent
- Have a reliable caregiver available
- No severe cognitive impairment that would preclude reliable reporting of adverse events or efficacy during treatment
Who cannot take part
- History of seizures or convulsions, or a seizure within 6 months prior to enrolment
- Previous neuromodulation treatment (e.g., rTMS or tDCS) within the past year
- History of severe traumatic brain injury or intracranial neurosurgery
- Presence of cardiac pacemakers, cochlear implants, intracranial implanted electronic devices, or other MRI-contraindicated ferromagnetic implants
- Severe cognitive impairment (Mini-Mental State Examination [MMSE] score ≤ 9) or severe visual, auditory, or speech dysfunction preventing cooperation with scale assessments and study procedures
- Skin breakdown or inflammation at the electrode placement site, or known allergy to conductive gel or electrode patch adhesives
- Pregnant or lactating women, or women of childbearing age not using reliable contraception
- Currently participating in other interventional clinical trials, or planning to participate in other trials that might affect the outcome assessment of this study during the study period
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Spinocerebellar ataxia type 3
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of this research study is to identify the optimal biological dose for tTIS that targets DN in SCA3 while achieving the best possible balance between therapeutic efficacy and safety.
The 3 groups in the trial
- 30 Hz Difference Frequency tTISTreatment being tested
Transcranial Temporal Interference Stimulation (tTIS) uses a difference frequency (Δf) of 30 Hz.
Treatment: Transcranial Temporal Interference Stimulation (tTIS)
- 40 Hz Difference Frequency tTISTreatment being tested
Transcranial Temporal Interference Stimulation (tTIS) uses a difference frequency (Δf) of 40 Hz.
Treatment: Transcranial Temporal Interference Stimulation (tTIS)
- 70 Hz Difference Frequency tTISTreatment being tested
Transcranial Temporal Interference Stimulation (tTIS) uses a difference frequency (Δf) of 70 Hz.
Treatment: Transcranial Temporal Interference Stimulation (tTIS)
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Efficacy and Safety of Transcranial Temporal Interference Stimulation of the Cerebellar Dentate Nucleus Using Individualized Head Modeling in Patients With Spinocerebellar Ataxia Type 3
- Criteria questions
- Built from NCT07743866, who can take part
- Record updated
- 1 September 2026